Nidanilimab
Nidanilimab (CAN04) is a fully humanized IL1RAP monoclonal antibody with a Kd value of 1.10 pM. It exhibits antitumor activity by disrupting the IL1α and IL1β signaling pathways and inducing the immune system to destroy tumor cells. Nidanilimab can be used to study solid cancers, such as non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC) .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
CAS Number
2171061-85-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
201-12-4215 96 Tests
Human Matrix Remodelling Associated Protein 5 (MXRA5) ELISA Kit
Ask
View Details 
MBS2906822-01 48 Well
Human ARL6IP1/ADP-ribosylation factor-like protein 6-interacting protein 1 ELISA Kit
Ask
View Details 
MBS2906822-02 96 Well
Human ARL6IP1/ADP-ribosylation factor-like protein 6-interacting protein 1 ELISA Kit
Ask
View Details MBS2906822-03 5x 96 Well
Human ARL6IP1/ADP-ribosylation factor-like protein 6-interacting protein 1 ELISA Kit
Ask
View Details MBS2906822-04 10x 96 Well
Human ARL6IP1/ADP-ribosylation factor-like protein 6-interacting protein 1 ELISA Kit
Ask
View Details